Therapeutic Implications of Tumor Physiology
Overview
Authors
Affiliations
The advent of genetic engineering and hybridoma technology has led to the design and large-scale production of various novel therapeutic agents for the treatment of cancer. However, these agents have not yet realized their clinical potential, presumably due to physiologic resistance inherent in tumors. An improved understanding of tumor physiology is necessary for development of more effective cancer therapy regimens. This article discusses the physiologic barriers to the delivery of these agents to tumors and some strategies to overcome or exploit tumor physiology for therapeutic benefit.
Intra-arterial adenoviral mediated tumor transfection in a novel model of cancer gene therapy.
Cabrera G, Porvasnik S, DiCorleto P, Siemionow M, Goldman C Mol Cancer. 2006; 5:32.
PMID: 16899125 PMC: 1560393. DOI: 10.1186/1476-4598-5-32.
Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice.
Pradeep C, Kuttan G Clin Exp Metastasis. 2003; 19(8):703-8.
PMID: 12553376 DOI: 10.1023/a:1021398601388.
Rodrigues L, Robinson S, McSheehy P, Stubbs M, Griffiths J Neoplasia. 2002; 4(6):539-43.
PMID: 12407448 PMC: 1503668. DOI: 10.1038/sj.neo.7900259.
Abels C, Heil P, Dellian M, Kuhnle G, Baumgartner R, Goetz A Br J Cancer. 1994; 70(5):826-33.
PMID: 7947087 PMC: 2033536. DOI: 10.1038/bjc.1994.406.
Averbach A, Stuart O, Sugarbaker T, Stephens A, Shamsa F, Sugarbaker P Ann Surg Oncol. 1995; 2(4):325-31.
PMID: 7552622 DOI: 10.1007/BF02307065.